Construction has begun on an Amgen Biomanufacturing plant in New Albany, Central Ohio. The facility will be utilized as a final product assembly and packaging plant to service Amgen’s rising demand in the United States, and it is projected to be operational by 2024. Amgen has been at the vanguard of biological medical innovation for more than 40 years, supporting patients with significant conditions in cancer, inflammation, cardiovascular disease, bone health, neurology, and nephrology.
Also Read:Â Cleveland Clinic Euclid Hospital expansion planned, Ohio
Sandra Rodriguez-Toledo, vice president of Site Operations at the Amgen Biomanufacturing plant Ohio, will lead the new site, which is currently known as Amgen Ohio. “When fully operational, Amgen Ohio will be a cutting-edge production facility that will allow us to continue to provide new revolutionary medications to every patient, every time. We have recently begun hiring for technicians and engineers, as well as quality assurance, quality control, administrative, and management jobs, and will continue to do so in the future. I’m happy to be in the Columbus area, and I’m looking forward to welcoming new Amgen colleagues.”
Details on Amgen Ohio
Turner Construction is in charge of the project’s construction management, and CRB Group is in charge of the design. “We intend to invest $365 million in the construction of this location,” stated Sam Guhan, vice president of Engineering at Amgen. “Environmental sustainability will be a top emphasis, and we hope to design and build this factory to be LEED-certified. We will enhance energy efficiency and waste reduction, furthering Amgen’s goal of being carbon neutral over the next several years.”
“Amgen’s decision to build a cutting-edge facility where approximately 400 Ohioans will assemble and package medicines that will improve the lives of millions of people suffering from serious illnesses around the world is fantastic news for the state of Ohio. Amgen’s newest factory will be it is most efficient and sustainable ever, demonstrating the benefits of leveraging Ohio’s biotech skill and inventiveness “Ohio Governor Mike DeWine said.
